Clinical Outcomes Solutions and BioSpark AI Technologies Inc. Unveil COA-AI Software
TUCSON, Ariz., December 15, 2023 (VSNewsNetwork.com) - Clinical Outcomes Solutions (COS), in collaboration with BioSpark AI Technologies Inc., launched COA-AI, a new software designed to integrate Artificial Intelligence (AI) into Clinical Outcomes Assessment (COA). This development marks a significant advancement in the field of clinical research, bringing AI capabilities to the forefront of clinical outcomes evaluation.
COA-AI was created to enhance the development of conceptual models, identification of outcome measures, and the synthesis of COA evidence. The software aims to streamline these key processes in clinical outcomes research, making them more efficient and effective.
Stacie Hudgens, CEO of Clinical Outcomes Solutions, emphasized the importance of the software’s launch, stating, “The launch of this software was quite timely for the field of COA as it ensures that we can provide accurate and timely COA desk research to support life science companies with a patient-focused strategy for their clinical development programs. This software allows for the synthesis and presentation of published information in an expedited manner while retaining the touch of an experienced researcher.”
Kristian Thorlund, CEO of BioSpark AI Technologies Inc., discussed the transformative impact of COA-AI: “Large language models have taken the world by storm, and Clinical Outcomes Assessment is next. The COA-AI software is a perfect fusion of human touch and AI innovation. The software’s AI models replicate key components of the robust workflow and research infrastructure that the team at Clinical Outcomes Solutions has spent so many years perfecting. It is almost perplexing to think about how much time this will save COA researchers in the future.”
Tara Symonds, CSO of Clinical Outcomes Solutions, outlined the practical benefits of the software: “This new COA-AI system, designed to bring together the use of AI and researcher insight, will help expedite our ability to quickly develop robust conceptual models to enable dialogue with clients about their COA endpoint strategy, and then based on this, help quickly decide on best COA measures. This will provide clients, often time-constrained, with a rapid solution to deciding which COA measures to include in forthcoming clinical trials.”
The launch of COA-AI by Clinical Outcomes Solutions and BioSpark AI Technologies Inc. reflects their commitment to advancing patient care and clinical research through technological innovation.
For additional details, visit www.clinoutsolutions.com.
Source: Clinical Outcomes Solutions via Newswire
